2 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 4, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Azithromycin 250 mg: new trials by email Literature Review of Azithromycin 250 mg trials Research Report on Azithromycin 250 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation | Phase 4 | Not yet recruiting | Sidra Aziz | 70 | 2027-02-01 | 2026-08-31 |
| Azithromycin to Modify Bronchiectasis Exacerbation Risk Standard Bronchiectasis Care, Azithromycin, Matching Placebo - Non-cystic Fibrosis Bronchiectasis, Bronchiectasis Adult | Phase 4 | Recruiting | Assiut University | 500 | 2026-06-29 | 2026-09-24 |
| Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Hydroxychloroquine 200 Mg Oral Tablet, Azithromycin 250 MG - SARS-CoV-2 Pneumonia, COVID-19 | Phase 3 | Unknown | Centre Hôpital Universitaire Farhat Hached | 200 | 2020-07-01 | 2020-06-19 |
| CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin - Lung Infection, MAC Lung Disease | Phase 3 | Recruiting | Centre Hospitalier Universitaire, Amiens | 424 | 2018-02-05 | 2025-11-19 |
| Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis Azithromycin 250 mg - Tuberculosis, Pulmonary | Phase 2 | Completed | University Medical Center Groningen | 24 | 2018-02-01 | 2024-02-26 |
| AZISAST Study: AZIthromycin in Severe ASThma Study Azithromycin 250 mg, Placebo - Asthma | Phase 4 | Completed | University Hospital, Ghent | 109 | 2009-03-01 | 2014-06-26 |
Asthma (1) · Bronchiectasis (1) · COVID-19 (1) · Pulmonary Disease, Chronic Obstructive (1) · Tuberculosis, Pulmonary (1)
Assiut University (1) · Centre Hospitalier Universitaire, Amiens (1) · Centre Hôpital Universitaire Farhat Hached (1) · Sidra Aziz (1) · University Hospital, Ghent (1) · University Medical Center Groningen (1)
Belgium (1) · Egypt (1) · France (1) · Netherlands (1) · Tunisia (1)
Ahmad M. Shaddad, MD (1) · Alaa S. Ali (1) · Aliae M. Hussien, MD (1) · Guy Brusselle, MD, PhD (1) · Maiada K. Hashem, MD (1)